Literature DB >> 21289222

DNA methylation in metabolic disorders.

Romain Barres1, Juleen R Zierath.   

Abstract

DNA methylation is a major epigenetic modification that controls gene expression in physiologic and pathologic states. Metabolic diseases such as diabetes and obesity are associated with profound alterations in gene expression that are caused by genetic and environmental factors. Recent reports have provided evidence that environmental factors at all ages could modify DNA methylation in somatic tissues, which suggests that DNA methylation is a more dynamic process than previously appreciated. Because of the importance of lifestyle factors in metabolic disorders, DNA methylation provides a mechanism by which environmental factors, including diet and exercise, can modify genetic predisposition to disease. This article considers the current evidence that defines a role for DNA methylation in metabolic disorders.

Entities:  

Mesh:

Year:  2011        PMID: 21289222     DOI: 10.3945/ajcn.110.001933

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  55 in total

Review 1.  Epigenomics, gestational programming and risk of metabolic syndrome.

Authors:  M Desai; J K Jellyman; M G Ross
Journal:  Int J Obes (Lond)       Date:  2015-02-02       Impact factor: 5.095

2.  Epigenetics lights up the obesity field.

Authors:  Amelia Marti; Jose Ordovas
Journal:  Obes Facts       Date:  2011-06-17       Impact factor: 3.942

3.  DNA methylation provides insight into intergenerational risk for preterm birth in African Americans.

Authors:  Sasha E Parets; Karen N Conneely; Varun Kilaru; Ramkumar Menon; Alicia K Smith
Journal:  Epigenetics       Date:  2015-06-19       Impact factor: 4.528

4.  Dietary modifications, weight loss, and changes in metabolic markers affect global DNA methylation in Hispanic, African American, and Afro-Caribbean breast cancer survivors.

Authors:  Lissette Delgado-Cruzata; Wenfei Zhang; Jasmine A McDonald; Wei Yann Tsai; Cristina Valdovinos; Laura Falci; Qiao Wang; Katherine D Crew; Regina M Santella; Dawn L Hershman; Heather Greenlee
Journal:  J Nutr       Date:  2015-02-04       Impact factor: 4.798

5.  Linoleic and α-linolenic fatty acid consumption over three generations exert cumulative regulation of hepatic expression of genes related to lipid metabolism.

Authors:  Carolina B Jacometo; Eduardo Schmitt; Luiz F M Pfeifer; Augusto Schneider; Francielle Bado; Fernanda T da Rosa; Simone Halfen; Francisco A B Del Pino; Juan J Loor; Marcio N Corrêa; Nelson J L Dionello
Journal:  Genes Nutr       Date:  2014-05-20       Impact factor: 5.523

6.  Global DNA methylation levels in human adipose tissue are related to fat distribution and glucose homeostasis.

Authors:  Maria Keller; Susan Kralisch; Kerstin Rohde; Dorit Schleinitz; Arne Dietrich; Michael R Schön; Daniel Gärtner; Tobias Lohmann; Miriam Dreßler; Anke Tönjes; Michael Stumvoll; Peter Kovacs; Mathias Fasshauer; Matthias Blüher; Yvonne Böttcher
Journal:  Diabetologia       Date:  2014-08-22       Impact factor: 10.122

7.  Relationship between expression and methylation of obesity-related genes in children.

Authors:  Veronica Davé; Paul Yousefi; Karen Huen; Vitaly Volberg; Nina Holland
Journal:  Mutagenesis       Date:  2015-01-14       Impact factor: 3.000

Review 8.  Maternal cholesterol levels during gestation: boon or bane for the offspring?

Authors:  V S Jayalekshmi; Surya Ramachandran
Journal:  Mol Cell Biochem       Date:  2020-09-22       Impact factor: 3.396

Review 9.  Epigenetic control of gene regulation during development and disease: A view from the retina.

Authors:  Ximena Corso-Díaz; Catherine Jaeger; Vijender Chaitankar; Anand Swaroop
Journal:  Prog Retin Eye Res       Date:  2018-03-12       Impact factor: 21.198

10.  Young children's family history of stuttering and their articulation, language and attentional abilities: An exploratory study.

Authors:  Dahye Choi; Edward G Conture; Victoria Tumanova; Chagit E Clark; Tedra A Walden; Robin M Jones
Journal:  J Commun Disord       Date:  2017-11-26       Impact factor: 2.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.